Comparison of the efficacy and side effects of Desmopressin melting tablets and nasal spray in the treatment of primary enuresis in children aged 6 to 12 years

Phase 3

Recruiting

• Conditions: Enuresis.; nonorganic enuresis; F98.0

• Registration Number: IRCT20230902059325N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

6 to 12 years old
Single-symptom nocturnal enuresis
Able to use nasal spray or sublingual tablets
Completion of the informed consent form by the guardian or legal guardian
At least two weeks before the start of the study, he did not receive any medicine

Exclusion Criteria

Having a history of organic urological disease, daily urinary incontinence, diabetes insipidus, or persistent urinary tract infection
Having clinically significant renal, hepatic, gastrointestinal, pulmonary, cardiovascular, endocrine, or neurological disease that interferes with evaluation
Using antibiotics, diuretics or any medicine that affects the concentration of urine
Failure to complete the informed consent form

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
octuria frequency. Timepoint: The period before the study, during one month after starting the drug and the follow-up period three months later. Method of measurement: Recording wet or dry nights in a notebook, by parents.